The Impact of COVID-19 on Lung Cancer Patients

The global COVID-19 pandemic has led to changes in public health measures causing significant disruption across lung cancer screening, diagnosis, treatment and management pathways. The pandemic has presented many challenges for lung cancer patients. These measures have also impacted people's behaviour and their interaction with the healthcare system. Therefore, increased knowledge of the broader as well as biological impacts of COVID-19 on lung cancer patients' health, is required.

To help address this need, BMC Pulmonary Medicine has launched this call for papers to bring together research on:

• characterising the interaction of COVID-19 and lung cancer, 
• health-related behaviour changes impacting lung cancer patients,
• the effect of changes to lung cancer care pathways,
• and the long term impact of the pandemic on lung cancer patients. 

We also encourage submissions discussing what we can learn from the pandemic to help build a better future for lung cancer research and care.

Asst. Prof. Michele Mondoni

Michele Mondoni is an Assistant Professor of Respiratory Medicine at the University of Milan, and works within the Pulmonology Unit of ASST Santi Paolo e Carlo. He graduated from the University of Milan in 2002 and received his II Level Master Degree in Interventional Pulmonology and Pulmonary Immunopathology at the University of Parma in 2011. His main areas of expertise are interventional pulmonology and interstitial lung diseases. His research interests include clinical and interventional pulmonology and ILDs. He joined the Editorial Board of BMC Pulmonary Medicine in 2018 and is Senior Editorial Board Member since 2020. 

Dr Jian Wu

Dr Jian Wu works within the State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University. Dr Wu 's research interests include the biological effects and clinical outcomes of COVID-19 on patients.

This Collection will consider research, database and software articles. Review articles will be considered at the discretion of the Journal’s Editor. If you would like to submit a review article, please first email Jennifer Harman <jennifer.harman@springernature.com> - the Editor of BMC Pulmonary Medicine. Please note that unsolicited reviews will not be considered as per our submission guidelines.

Articles under consideration for publication within the collection will be assessed according to the standard BMC Pulmonary Medicine editorial criteria and will undergo the journal’s standard peer-review process overseen by Editorial Board Members Dr Michele Mondoni (ASST Santi Paolo e Carlo, Italy) and Dr Jian Wu (Zhejiang University, China).

Before submitting your manuscript, please ensure you have carefully read the submission guidelines for BMC Pulmonary Medicine. Please ensure you highlight in your cover letter that you are submitting to a collection. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "The Impact of COVID-19 on Lung Cancer Patients". 

If accepted for publication, an article processing charge applies. Please click here to find out about our standard waiver policy.

The Collection opens on 1 May 2022 and closes on 1 October 2023.